XBiotech

XBiotech Inc. is a biopharmaceutical company pioneering the discovery and development of True Human™ antibodies for treating diseases with unmet medical needs. The company focuses on developing therapeutic antibodies that are naturally produced by humans who possess immunity to certain diseases. Their approach aims to leverage the body's own natural defense mechanisms to fight disease.

XBiotech's technology platform centers around identifying and cloning these naturally occurring human antibodies directly from individuals with desired immune responses. They then develop these antibodies as potential therapeutic agents for a variety of conditions. Key areas of therapeutic focus have included inflammatory diseases, cancer, and infectious diseases.

The company has historically pursued various clinical trials to evaluate the safety and efficacy of its antibody therapies. Further information about specific drug candidates and ongoing clinical programs can be found on the company's official website or through publicly available regulatory filings.